FDA-Cleared BabySat® Monitoring System

Product Description

Introducing the BabySat® monitoring system, a prescription and is intended for babies aged 1-18 months and between 6-30 lbs who could benefit from additional monitoring at home, under the supervision of a physician due to ongoing medical needs. Indications for BabySat often include babies with underlying Cardiac or Respiratory conditions.